168 related articles for article (PubMed ID: 38017457)
1. The effects of Olmesartan/amlodipine administered in the Morning or At Night on nocturnal blood pressure reduction in Chinese patients with mild-moderate essential hypertension (OMAN Trial): study protocol for a prospective, multicenter, randomized, open-label clinical trial {1}.
Xu M; Zhang X; Ye R; Liu X; Sun L; Jia S; Zhang Z; Li X; Wang Z; Liao H; Shi R; Liu K; Wang S; Meng Q; Chen X
Trials; 2023 Nov; 24(1):770. PubMed ID: 38017457
[TBL] [Abstract][Full Text] [Related]
2. The bedtime administration ameliorates blood pressure variability and reduces urinary albumin excretion in amlodipine-olmesartan combination therapy.
Hoshino A; Nakamura T; Matsubara H
Clin Exp Hypertens; 2010; 32(7):416-22. PubMed ID: 20828223
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of olmesartan/amlodipine/hydrochlorothiazide in patients with hypertension not at goal with mono, dual or triple drug therapy: results of the CHAMPiOn study.
Punzi HA
Ther Adv Cardiovasc Dis; 2014 Feb; 8(1):12-21. PubMed ID: 24492985
[TBL] [Abstract][Full Text] [Related]
4. Chronotherapy with valsartan/amlodipine fixed combination: improved blood pressure control of essential hypertension with bedtime dosing.
Hermida RC; Ayala DE; Fontao MJ; Mojón A; Fernández JR
Chronobiol Int; 2010 Jul; 27(6):1287-303. PubMed ID: 20653455
[TBL] [Abstract][Full Text] [Related]
5. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS;
Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
[TBL] [Abstract][Full Text] [Related]
6. Sleep-time ambulatory blood pressure as a prognostic marker of vascular and other risks and therapeutic target for prevention by hypertension chronotherapy: Rationale and design of the Hygia Project.
Hermida RC
Chronobiol Int; 2016; 33(7):906-36. PubMed ID: 27221952
[TBL] [Abstract][Full Text] [Related]
7. Effects of combination therapy with amlodipine and fosinopril administered at different times on blood pressure and circadian blood pressure pattern in patients with essential hypertension.
Meng Y; Zhang Z; Liang X; Wu C; Qi G
Acta Cardiol; 2010 Jun; 65(3):309-14. PubMed ID: 20666269
[TBL] [Abstract][Full Text] [Related]
8. Comparison of morning vs bedtime administration of the combination of valsartan/amlodipine on nocturnal brachial and central blood pressure in patients with hypertension.
Fujiwara T; Hoshide S; Yano Y; Kanegae H; Kario K
J Clin Hypertens (Greenwich); 2017 Dec; 19(12):1319-1326. PubMed ID: 29106031
[TBL] [Abstract][Full Text] [Related]
9. Blood pressure-lowering efficacy and safety of perindopril/indapamide/amlodipine single-pill combination in patients with uncontrolled essential hypertension: a multicenter, randomized, double-blind, controlled trial.
Mourad JJ; Amodeo C; de Champvallins M; Brzozowska-Villatte R; Asmar R;
J Hypertens; 2017 Jul; 35(7):1481-1495. PubMed ID: 28306636
[TBL] [Abstract][Full Text] [Related]
10. A comparative study for the effects of nifedipine GITS and amlodipine besylate administrated in daytime or at nighttime on recovery of blood pressure rhythm and arterial stiffness in the young and middle-aged subjects with non-dipper hypertension (NARRAS): Design and rationale.
Liu J
Int J Clin Pract; 2020 Dec; 74(12):e13628. PubMed ID: 32726499
[TBL] [Abstract][Full Text] [Related]
11. Fixed-combination of amlodipine and diuretic chronotherapy in the treatment of essential hypertension: improved blood pressure control with bedtime dosing-a multicenter, open-label randomized study.
Zeng J; Jia M; Ran H; Tang H; Zhang Y; Zhang J; Wang X; Wang H; Yang C; Zeng C
Hypertens Res; 2011 Jun; 34(6):767-72. PubMed ID: 21471971
[TBL] [Abstract][Full Text] [Related]
12. Twenty-Four-Hour Blood Pressure-Lowering Efficacy of Sacubitril/Valsartan Versus Olmesartan in Japanese Patients With Essential Hypertension Based on Nocturnal Blood Pressure Dipping Status: A Post Hoc Analysis of Data From a Randomized, Double-Blind Multicenter Study.
Kario K; Rakugi H; Yarimizu D; Morita Y; Eguchi S; Iekushi K
J Am Heart Assoc; 2023 Apr; 12(8):e027612. PubMed ID: 37026551
[TBL] [Abstract][Full Text] [Related]
13. Chronotherapy with valsartan/hydrochlorothiazide combination in essential hypertension: improved sleep-time blood pressure control with bedtime dosing.
Hermida RC; Ayala DE; Mojón A; Fontao MJ; Fernández JR
Chronobiol Int; 2011 Aug; 28(7):601-10. PubMed ID: 21823969
[TBL] [Abstract][Full Text] [Related]
14. MASked-unconTrolled hypERtension management based on office BP or on ambulatory blood pressure measurement (MASTER) Study: a randomised controlled trial protocol.
Parati G; Agabiti-Rosei E; Bakris GL; Bilo G; Branzi G; Cecchi F; Chrostowska M; De la Sierra A; Domenech M; Dorobantu M; Faria T; Huo Y; Jelaković B; Kahan T; Konradi A; Laurent S; Li N; Madan K; Mancia G; McManus RJ; Modesti PA; Ochoa JE; Octavio JA; Omboni S; Palatini P; Park JB; Pellegrini D; Perl S; Podoleanu C; Pucci G; Redon J; Renna N; Rhee MY; Rodilla Sala E; Sanchez R; Schmieder R; Soranna D; Stergiou G; Stojanovic M; Tsioufis K; Valsecchi MG; Veglio F; Waisman GD; Wang JG; Wijnmaalen P; Zambon A; Zanchetti A; Zhang Y
BMJ Open; 2018 Dec; 8(12):e021038. PubMed ID: 30573476
[TBL] [Abstract][Full Text] [Related]
15. Effect of Fimasartan versus Valsartan and Olmesartan on Office and Ambulatory Blood Pressure in Korean Patients with Mild-to-Moderate Essential Hypertension: A Randomized, Double-Blind, Active Control, Three-Parallel Group, Forced Titration, Multicenter, Phase IV Study (Fimasartan Achieving Systolic Blood Pressure Target (FAST) Study).
Chung WB; Ihm SH; Jang SW; Her SH; Park CS; Lee JM; Chang K; Jeon DS; Yoo KD; Seung KB
Drug Des Devel Ther; 2020; 14():347-360. PubMed ID: 32158190
[TBL] [Abstract][Full Text] [Related]
16. Ambulatory blood pressure monitoring in the prediction of cardiovascular events and effects of chronotherapy: rationale and design of the MAPEC study.
Hermida RC
Chronobiol Int; 2007; 24(4):749-75. PubMed ID: 17701685
[TBL] [Abstract][Full Text] [Related]
17. Switching therapy to bedtime for uncontrolled hypertension with a nondipping pattern: a prospective randomized-controlled study.
Farah R; Makhoul N; Arraf Z; Khamisy-Farah R
Blood Press Monit; 2013 Aug; 18(4):227-31. PubMed ID: 23660686
[TBL] [Abstract][Full Text] [Related]
18. Bedtime administration of long-acting antihypertensive drugs restores normal nocturnal blood pressure fall in nondippers with essential hypertension.
Takeda A; Toda T; Fujii T; Matsui N
Clin Exp Nephrol; 2009 Oct; 13(5):467-472. PubMed ID: 19449087
[TBL] [Abstract][Full Text] [Related]
19. Effects of combination olmesartan medoxomil plus azelnidipine versus monotherapy with either agent on 24-hour ambulatory blood pressure and pulse rate in Japanese patients with essential hypertension: additional results from the REZALT study.
Shimada K; Ogihara T; Saruta T; Kuramoto K;
Clin Ther; 2010 May; 32(5):861-81. PubMed ID: 20685495
[TBL] [Abstract][Full Text] [Related]
20. Antihypertensive efficacy of night-time graded-release diltiazem versus morning amlodipine in African Americans.
Wright JT; Sica DA; Gana TJ; Bohannon K; Pascual LG; Albert KS
Am J Hypertens; 2004 Sep; 17(9):734-42. PubMed ID: 15363813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
